Description
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
| Purity | ≥70% |
|---|---|
| Formula | C16H14N2O4 |
| Formula Wt. | 298.29 |
| Appearance | Red Powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
Enalapril metabolite; ACE inhibitor.
Alkaloid compound originally found in Corydalis...
Endogenous anionic non-sulfated glycosaminoglyc...
Nonpeptide angiotensin II receptor antagonist
Semi-synthetic diterpene originally found in Ta...
Cyclohexanecarboxylic acid found in various pla...
Tretraeptide, binds cell surface integrins.
Phenothiazine; D1/2 and α1-adrenergic antagoni...
Endogenous tachykinin peptide, involved in infl...
EGFR inhibitor.
Endogenous coenzyme, unit of cellular energy, r...
NSAID; COX-2 inhibitor.
5-fluorouracil prodrug, pyrimidine analog; thym...
Fluoroquinolone; topoisomerase IV and bacterial...
A peroxisome proliferator-activated receptor ag...
Alkaloid found in black and long peppers; TRPV1...
VEGFR inhibitor.
Pleuromutilin
Triazole; demethylation inhibitor.
ITC, erysolin analog.